Evidence map›Paper›PMID 31535191›Full record

ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2020

Ongoing MRI remodeling 3-7 years after collagen meniscus implantation in stable knees.

L Schenk, L Bethge, A Hirschmann, R Berbig, U Lüthi, M P Arnold, Michael T Hirschmann

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06775197 (Sterile Allogeneic Spongioflex® Allograft As Partial Meniscal Replacement After Incomplete Meniscal Loss, an Investigator-initiated Trial), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06775197 phase4recruitingnot on this mapstarted 2024, after this paper: background citation

Sterile Allogeneic Spongioflex® Allograft As Partial Meniscal Replacement After Incomplete Meniscal Loss, an Investigator-initiated Trial

TypeinterventionalSponsorMaria-Josef-Hospital GrevenRan2024 to 2031Enrolled40ConditionsPartial Meniscal Loss, Lateral Meniscus Partial Loss, Medial Meniscal Partial Loss, Meniscus LesionArmspartial meniscal replacement with Spongioflex®
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Three-dimensional-printed shape-memory composite scaffold for meniscus repair.The Journal of international medical research · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. The Current State of Meniscus Replacements.Current reviews in musculoskeletal medicine · 2024
    Review
  7. Biologic Augmentation of Isolated Meniscal Repair.Current reviews in musculoskeletal medicine · 2024
    Review
  8. Article
  9. Natural biopolymer scaffold for meniscus tissue engineering.Frontiers in bioengineering and biotechnology · 2022
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. A professional athlete functionally active 10 years after an arthroscopic lateral collagen meniscus implant.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2021
    Article
  15. Article
  16. Meniscal substitution, a developing and long-awaited demand.Journal of experimental orthopaedics · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

L SchenkDepartment of Orthopaedic Surgery and Traumatology, Kantonsspital Baselland (Bruderholz, Liestal, Laufen), 4101, Bruderholz, Switzerland.
L BethgeDepartment of Orthopaedic Surgery and Traumatology, Kantonsspital Baselland (Bruderholz, Liestal, Laufen), 4101, Bruderholz, Switzerland.
A HirschmannRadiology and Nuclear Medicine, University Basel Hospital, Basel, Switzerland.
R BerbigSportclinic Zürich, Zurich, Switzerland.
U LüthiSportclinic Zürich, Zurich, Switzerland.
M P ArnoldLEONARDO, Clinic Hirslanden Birshof, Münchenstein, Switzerland.
Michael T HirschmannDepartment of Orthopaedic Surgery and Traumatology, Kantonsspital Baselland (Bruderholz, Liestal, Laufen), 4101, Bruderholz, Switzerland. michael.hirschmann@ksbl.ch.ORCID http://orcid.org/0000-0002-4014-424X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of the present study was to evaluate the clinical and radiological 3-7 years outcomes of patients who underwent collagen meniscus implantation in stable or stabilized knees. It was the hypothesis that using the collagen meniscus (CMI) good clinical 3-7 years outcomes with low pain levels are achieved.

methodsThirty-nine patients (male:female = 30:9, mean age 34 ± 10 years) underwent arthroscopic CMI after subtotal medial (n = 32) or lateral meniscectomy (n = 7). A 7-mm CMI was performed due to prophylactic (n = 25) or therapeutic indication (n = 14). IKDC score, Tegner score preinjury, preoperatively and at follow-up, Lysholm score and visual analogue scale for pain and satisfaction (follow-up rate 90%) were assessed. MRI scans were analyzed according to the Genovese criteria (n = 19). Implant failure was defined as infection or mechanical failure of the device. The minimum follow-up time was 36 months (range 36-84 months).

resultsThe mean VAS satisfaction preoperatively and at follow-up was 4.0 ± 0 and 1.6 ± 1.0. The mean VAS pain was 4.3 ± 3.2 preoperatively and at last follow-up 2.1 ± 1.7. The median Tegner score preinjury was 7 (range 3-10), it decreased preoperatively to median 3.5 (range 1-8) and nearly reached the preinjury level at last follow-up 6 (range 3-10). The mean Lysholm score before surgery was 66 ± 20 and 91 ± 8 at last follow-up. Seven patients (38.9%) had a normal total IKDC score (A), 10 patients were nearly normal (B) and 1 patient slightly abnormal (C). In MRI the CMI was entirely resorbed in 4 patients (21%) and partially resorbed in 15 (79%). In 4 patients (21%) the CMI was isointense, in 14 (74%) slightly hyperintense and in 1 (5%) highly hyperintense. Ten patients (53%) showed marked signs of bone marrow edema. In 13 patients (68%) an extrusion of the meniscus > 3 mm at last follow-up was found.

conclusionsMeniscal substitution with the CMI showed good to excellent clinical 3-7 results. The CMI shows an ongoing remodelling with decreased signal intensity and decreased size. However, as meniscus extrusion remained at the same level and bone marrow edema decreased from 1 year to longer term follow-up, it appears that the remodeling comes to an end at about 5 years after CMI. LEVEL OF EVIDENCE: IV.

Indexed as

Magnetic Resonance ImagingProsthesis ImplantationAdultArthroscopyBone Marrow DiseasesCollagenEdemaFemaleFollow-Up StudiesHumansMaleMeniscectomyMenisci, TibialOrthopedic ProceduresPainPain MeasurementCollagenACL reconstructionCartilageCollagen meniscus implantExtrusionIKDCLysholmMeniscal substitutionMRIOutcomesTegner

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.